Single-cell mtDNA heteroplasmy in colorectal cancer

João Almeida; Andrés Pérez‐Figueroa; João M. Alves; Monica Valecha; Sonia Prado‐Lòpez; Pilar Alvariño; José Cameselle‐Teijeiro; Débora Chantada; Miguel M. Fonseca; David Posada

doi:10.1016/j.ygeno.2022.110315

Preprint2021

Single-cell mtDNA heteroplasmy in colorectal cancer

João Almeida, Andrés Pérez‐Figueroa, João M. Alves, Monica Valecha, Sonia Prado‐Lòpez, Pilar Alvariño, José Cameselle‐Teijeiro, Débora Chantada, Miguel M. Fonseca, David Posada

Article2018

Intra-tumor diversification in colorectal cancer at the single-cell level.

Nobuo Sasaki, Hans Clevers

Article2018

Intra-tumour diversification in colorectal cancer at the single-cell level

Sophie Roerink, Nobuo Sasaki, Henry Lee-Six, Matthew D. Young, Ludmil B. Alexandrov, Sam Behjati, Thomas J. Mitchell, Sebastian Großmann, Howard Lightfoot, David A. Egan, Apollo Pronk, Niels Smakman, Joost van Gorp, Elizabeth Anderson, Stephen J. Gamble, Christopher Alder, Marc van de Wetering, Peter J. Campbell, Michael R. Stratton, Hans Clevers

Preprint2025

Single-cell phylodynamics reveal rapid late-stage colorectal cancer expansions

João M. Alves, Kylie Chen, Sonia Prado‐Lòpez, Nuria Estévez‐Gómez, Pilar Alvariño, Juana Alonso, Monica Valecha, Laura Tomás‐Gallardo, Antoine Zwaans, Ugnė Stolz, Tanja Stadler, Débora Chantada, José Cameselle‐Teijeiro, Alexei J. Drummond, David Posada

Article2011

A novel mtDNA mutation determines sensitivity to cisplatin induced cancer cell death

Aleck W.E. Jones, Zhi Yao, Nicolas Tajeddine, Guido Guido Kroemer, Catherine Brenner, Mariusz R. Więckowski, Takehiro Yasukawa, Shamima Rahman, György Szabadkai

Single-cell mtDNA heteroplasmy in colorectal cancer

Discussion(0)

Related publications

Single-cell mtDNA heteroplasmy in colorectal cancer

Intra-tumor diversification in colorectal cancer at the single-cell level.

Intra-tumour diversification in colorectal cancer at the single-cell level

Single-cell phylodynamics reveal rapid late-stage colorectal cancer expansions

A novel mtDNA mutation determines sensitivity to cisplatin induced cancer cell death